Synovus Financial’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-21,458
Closed -$388K – 855
2023
Q2
$388K Sell
21,458
-864
-4% -$16.1K ﹤0.01% 672
2023
Q1
$374K Buy
22,322
+303
+1% +$5.93K ﹤0.01% 677
2022
Q4
$452K Buy
22,019
+937
+4% +$16.5K 0.01% 636
2022
Q3
$400K Buy
21,082
+487
+2% +$10.9K ﹤0.01% 631
2022
Q2
$484K Buy
20,595
+255
+1% +$7.3K 0.01% 594
2022
Q1
$666K Buy
20,340
+1,549
+8% +$49.8K 0.01% 534
2021
Q4
$588K Buy
18,791
+1,107
+6% +$37K 0.01% 594
2021
Q3
$676K Buy
17,684
+395
+2% +$15.7K 0.01% 539
2021
Q2
$694K Buy
17,289
+551
+3% +$23.3K 0.01% 529
2021
Q1
$730K Buy
16,738
+711
+4% +$31.3K 0.01% 469
2020
Q4
$695K Buy
16,027
+222
+1% +$8.11K 0.01% 464
2020
Q3
$492K Buy
15,805
+588
+4% +$18.2K 0.01% 500
2020
Q2
$486K Sell
15,217
-3,564
-19% -$118K 0.01% 468
2020
Q1
$531K Buy
18,781
+4,047
+27% +$157K 0.01% 502
2019
Q4
$678K Buy
14,734
+1,449
+11% +$68.1K 0.01% 402
2019
Q3
$699K Buy
+13,285
New +$685K 0.01% 392

Other funds holding OFIX

Synovus Financial's OFIX Position: Q3 2023 in Review

Synovus Financial sold out of Orthofix Medical (OFIX) in Q3 2023, closing a stake of 21,458 shares — an estimated $388K sold.

Synovus Financial first reported a position in OFIX in Q3 2019 and held it in 16 quarters. The position peaked at $730K in Q1 2021. 159 funds tracked by Wall St. Rank hold OFIX as of Q3 2023.

  • Synovus Financial reported no remaining Orthofix Medical position as of Q3 2023 after selling out during the quarter.
  • Synovus Financial sold 21,458 Orthofix Medical shares in Q3 2023, an estimated $388K.
  • Synovus Financial first reported a position in Orthofix Medical in Q3 2019 and held it in 16 quarters.
  • Synovus Financial's Orthofix Medical position peaked at $730K in Q1 2021.
  • 159 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2023.

Based on Synovus Financial's 13F filing for Q3 2023, filed 13 Nov 2023.